NICE TAs

28/04/2020

TA623: Patiromer for treating hyperkalaemia

28/04/2020

TA599: Sodium zirconium cyclosilicate for treating hyperkalaemia

23/04/2020

TA583: Ertugliflozin with metformin and a dipeptidyl peptidase-4 inhibitor for treating type 2 diabetes

23/04/2020

TA569: Pertuzumab for adjuvant treatment of HER2-positive early stage breast cancer

23/04/2020

TA543: Tofacitinib for treating active psoriatic arthritis after inadequate response to DMARDs

23/04/2020

TA547: Tofacitinib for moderately to severely active ulcerative colitis

23/04/2020

TA562: Encorafenib with binimetinib for unresectable or metastatic BRAF V600 mutation-positive melanoma

23/04/2020

TA621: Osimertinib for untreated EGFR mutation-positive non-small-cell lung cancer

23/04/2020

TA522: Liposomal cytarabine–daunorubicin for untreated acute myeloid leukaemia

23/04/2020

TA554: Tisagenlecleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people aged up to 25 years

23/04/2020

TA559: Axicabtagene ciloleucel for treating diffuse large B-cell lymphoma and primary mediastinal large B-cell lymphoma after 2 or more systemic therapies

23/04/2020

TA567: Tisagenlecleucel for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic therapies

23/04/2020

TA544: Dabrafenib with trametinib for adjuvant treatment of resected BRAF V600 mutation-positive melanoma

23/04/2020

TA557: Pembrolizumab with pemetrexed and platinum chemotherapy for untreated, metastatic, non-squamous non-small-cell lung cancer

23/04/2020

TA558: Nivolumab for adjuvant treatment of completely resected melanoma with lymph node involvement or metastatic disease

23/04/2020

TA551: Lenvatinib for untreated advanced hepatocellular carcinoma

22/04/2020

TA575: Tildrakizumab for treating moderate to severe plaque psoriasis

22/04/2020

TA574: Certolizumab pegol for treating moderate to severe plaque psoriasis

22/04/2020

TA607: Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease

22/04/2020

TA556: Darvadstrocel for treating complex perianal fistulas in Crohn's disease